Dr. Caitlyn R. Wasserman, MD

Dr. Wasserman practices at Brigham and Women's Faulkner Hospital in Jamaica Plain, Massachusetts, part of Mass General Brigham.

Dr. Wasserman's NPI, 1184114720, was assigned on May 17, 2018. Dr. Wasserman graduated from Albany Medical College of Union University in 2018. Dr. Wasserman holds Massachusetts license 287929.

Dr. Wasserman's primary practice is Brigham and Women's Faulkner Hospital, at 1153 Centre Street, Jamaica Plain, MA 02130 in Suffolk County. The practice phone is (617) 983-7000.

Dr. Wasserman's primary practice is Brigham and Women's Faulkner Hospital in Jamaica Plain, Massachusetts, part of Mass General Brigham. Dr. Wasserman is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Wasserman to 3 more hospitals and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wasserman practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Wasserman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Wasserman is licensed in Massachusetts.

CMS data shows 629 Medicare services from Dr. Wasserman across 5 procedure codes in 2024, for 216 Medicare patients. Medicare paid $49,936 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 216 Medicare patients who saw Dr. Wasserman in 2024. The largest group is 75 to 84, with 85 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wasserman's median patient age at 76, with 60% women.

In 2024, Dr. Wasserman wrote 117 Medicare Part D claims for 37 patients. 69% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $7,540 in total drug cost. In 2023, CMS named 174 claims across 9 drugs.

Dr. Wasserman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Wasserman, published from 2011 to 2014. The most frequent topics are AICDA (Activation-Induced Cytidine Deaminase), B-Lymphocytes and Cytidine Deaminase. Dr. Wasserman has published most often in Cell. Dr. Wasserman's most frequent co-authors are James Elliott Bradner, MD, Xiaoli Liu and Michel C. Nussenzweig, MD.

Dr. Wasserman graduated from Albany Medical College of Union University in 2018.